Evidence map›Paper›PMID 27774473›Full record

ArticleHypoxia (Auckland, N.Z.)2014

Arginine-vasopressin marker copeptin is a sensitive plasma surrogate of hypoxic exposure.

Louise Ostergaard, Alain Rudiger, Sven Wellmann, Elena Gammella, Beatrice Beck-Schimmer, Joachim Struck, Marco Maggiorini, Max Gassmann

Open access · diamondAbstract read
In one paragraph

Article in Hypoxia (Auckland, N.Z.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Review
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Louise OstergaardInstitute of Veterinary Physiology, Vetsuisse Faculty, University of Zürich; Zürich Center for Integrative Human Physiology.
Alain RudigerInstitute of Anesthesiology.
Sven WellmannZürich Center for Integrative Human Physiology; Division of Neonatology, University Hospital Zürich, Zürich; Department of Neonatology, University Children's Hospital Basel, Basel, Switzerland.
Elena GammellaDepartment of Human Morphology and Biomedical Science, University of Milan, Milan, Italy.
Beatrice Beck-SchimmerZürich Center for Integrative Human Physiology; Institute of Anesthesiology.
Joachim StruckResearch Department, B⋅R⋅A⋅H⋅M⋅S Biomarkers, Thermo Fisher Scientific, Hennigsdorf, Germany.
Marco MaggioriniZürich Center for Integrative Human Physiology; Medical Intensive Care Unit, University Hospital Zürich, Zürich, Switzerland.
Max GassmannInstitute of Veterinary Physiology, Vetsuisse Faculty, University of Zürich; Zürich Center for Integrative Human Physiology; Universidad Peruana Cayetano Heredia, Lima, Peru.
Swiss Integrative Center for Human Health · CHUniversity Hospital of Zurich · CHThermo Fisher Scientific (Germany) · DEUniversity of Milan · ITUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA reduced oxygen supply puts patients at risk of tissue hypoxia, organ damage, and even death. In response, several changes are activated that allow for at least partial adaptation, thereby increasing the chances of survival. We aimed to investigate whether the arginine vasopressin marker, copeptin, can be used as a marker of the degree of acclimatization/adaptation in rats exposed to hypoxia.

methodsSprague-Dawley rats were exposed to 10% oxygen for up to 48 hours. Arterial and right ventricular pressures were measured, and blood gas analysis was performed at set time points. Pulmonary changes were investigated by bronchoalveolar lavage, wet and dry weight measurements, and lung histology. Using a newly developed specific rat copeptin luminescence immunoassay, the regulation of vasopressin in response to hypoxia was studied, as was atrial natriuretic peptide (ANP) by detecting mid-regional proANP.

resultsWith a decreasing oxygen supply, the rats rapidly became cyanotic and inactive. Despite continued exposure to 10% oxygen, all animals recuperated within 16 hours and ultimately survived. Their systemic blood pressure fell with acute (5 minutes) hypoxia but was partially recovered over time. In contrast, right ventricular pressures increased with acute (5 minutes) hypoxia and normalized after 16 hours. No signs of pulmonary inflammation or edema were found despite prolonged hypoxia. Whereas copeptin levels increased significantly after acute (5 minutes) hypoxia and then returned to near baseline after 16 hours, mid-regional proANP levels were even further increased after 16 hours of exposure to hypoxia.

conclusionPlasma copeptin is a sensitive marker of acute (5 minutes) exposure to severe hypoxia, and subsequent regulation can indicate recovery. Copeptin levels can therefore reflect clinical and physiological changes in response to hypoxia and indicate recovery from ongoing hypoxic exposure.

Indexed as

acclimatizationadaptationatrial natriuretic peptidecopeptincritical illnesshypoxiavasoactive peptides

Identifiers

PMID27774473
PMCPMC5045063
OpenAlexW1996338173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.